Development of a thermoresistant tissue culture rinderpest vaccine virus.
The currently used Plowright's tissue culture rinderpest vaccine (RBOK strain) gives full protection and lifelong immunity, but it is highly thermolabile and requires maintenance of cold chain from vaccine production till delivery. Keeping in view the need for a thermostabile vaccine in tropical developing countries with limited refrigeration facilities, we passaged serially the RBOK strain of rinderpestvirus (RPV) at gradually elevated temperature up to 40 degrees C to obtain a thermoresistant RPV (TR-RPV) mutant. The thermoresistance (thermostability) and antigenicity of TR-RPV were compared with those of the vaccine virus by various methods, confirming the acquired properties. Thus, the infectivity titres of the TR-RPV mutant and vaccine virus were determined after incubation for various times at 37 degrees C. Regression analysis indicated that TR-RPV had a half-life of 1.81 hr and a degradation constant of 0.1656, while the parent vaccine virus had a half-life of 1.11 hr and a degradation constant of 0.2686. In capture ELISA with four different monoclonal antibodies (MAbs) to the N protein of RPV, TR-RPV showed a 10-fold higher reactivity with one MAb as compared to the vaccine virus. Although TR-RPV did react also with the other three MAbs, its reactivity was only 4-5 times higher than that of the vaccine virus. A treatment of the virus with Triton X-100 resulted in 2-4 times higher reactivity with the MAbs. The 35S-methionine-labeled vaccine virus-and TR-RPV-infected Vero cell lysates showed 6 polypeptide bands with identical pattern of migration in polyacrylamide gel electrophoresis in the presence of SDS (SDS-PAGE). Radioimmunoprecipitation assay (RIPA) of the TR-RPV and vaccine virus with a rabbit anti-RPV immune serum (RHIS) and bovine anti-RPV hyperimmune serum (BHIS) showed the presence of four identical antigenic proteins, namely H, N, F and M, for both viruses. It can be concluded that TR-RPV has indeed retained the antigenic properties of the parental vaccine virus besides acquiring thermoresistance.
Raut
A
A
National Biotechnology Center, Indian Veterinary Research Institute, Izatnagar.
Singh
R K
RK
Malik
M
M
Joseph
M C
MC
Bakshi
C S
CS
Suryanarayana
V V
VV
Butchaiah
G
G
D000818:Animals; D000956:Antigens, Viral / Q000276:immunology; D002417:Cattle; D002522:Chlorocebus aethiops; D004797:Enzyme-Linked Immunosorbent Assay; D006023:Glycoproteins / Q000276:immunology; D006389:Hemagglutinins, Viral; D007106:Immune Sera; D008565:Membrane Proteins; D009154:Mutation; D019251:Nucleocapsid / Q000276:immunology; D011817:Rabbits; D015531:Radioimmunoprecipitation Assay; D012302:Rinderpest virus / Q000235:genetics / Q000254:growth & development / Q000276:immunology*; D013696:Temperature; D014613:Vaccines, Attenuated / Q000276:immunology; D014709:Vero Cells; D014760:Viral Fusion Proteins / Q000276:immunology; D014763:Viral Matrix Proteins / Q000276:immunology; D014764:Viral Proteins / Q000276:immunology; D014765:Viral Vaccines / Q000276:immunology*
D000956:Antigens, Viral; C079748:F protein, Rinderpest virus; D006023:Glycoproteins; D006389:Hemagglutinins, Viral; D007106:Immune Sera; D008565:Membrane Proteins; D014613:Vaccines, Attenuated; D014760:Viral Fusion Proteins; D014763:Viral Matrix Proteins; D014764:Viral Proteins; D014765:Viral Vaccines; C079749:hemagglutinin protein, Rinderpest virus; C445504:matrixprotein, Rinderpest virus